From a clinical perspective, these findings provide hypothesis-generating evidence that integrating ERFE and hepcidin measurements with traditional anemia indices could enhance understanding of iron metabolism and erythropoietic adaptation in CKD. This evidence concerns the gene HAMP and anemia (phenotype).